Morales T I, Joyce M E, Sobel M E, Danielpour D, Roberts A B
Bone Research Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, MD 20892.
Arch Biochem Biophys. 1991 Aug 1;288(2):397-405. doi: 10.1016/0003-9861(91)90212-2.
Transforming growth factor beta 1 (TGF-beta 1) has been shown to play a prominent role in controlling proteoglycan synthesis and breakdown as measured following addition to organ cultures of calf articular cartilage (Morales, T. I., and Roberts, A. B., J. Biol. Chem., 263, 12,828-12,831, 1988). In this study, we compare two closely related TGF-beta isoforms, TGF-beta 1 and TGF-beta 2, both by assessing the effects of exogenous peptide as well as by analyzing the biosynthesis and total amount of these two isoforms in cartilage explants. Added exogenously, TGF-beta 1 and TGF-beta 2 induce a comparable increase in proteoglycan synthesis over basal controls with saturation at approximately 5 ng/ml. Synthesis of TGF-beta by basal calf cartilage cultures is demonstrated by (i) immunolocalization of intracellular TGF-beta, (ii) Northern blot analysis of steady-state mRNA levels, and (iii) immunoprecipitation of metabolically labeled TGF-beta from tissue extracts and conditioned culture medium. The net amount of extractable TGF-beta 1 and TGF-beta 2 in the basal cartilage cultures was assessed by a functional assay involving inhibition of proliferation of CCL-64 mink lung epithelial cells and by sandwich enzyme-linked immunosorbent assay. The predominant isoform was TGF-beta 1 (60-85%) and the total TGF-beta 1 + TGF-beta 2 was in excess of the amount required for maximal activation of proteoglycan synthesis. The level of both isoforms was maintained relatively constant between Days 2 and 7 of culture despite a sharp (approximately two to fourfold) drop in proteoglycan synthesis. This suggests that cartilage contains a large pool of TGF-beta which is not readily accessible to the chondrocyte. We propose that much of the polypeptide is sequestered in the matrix awaiting release upon demand.
转化生长因子β1(TGF-β1)已被证明在控制蛋白聚糖的合成和分解中发挥着重要作用,这是在向小牛关节软骨器官培养物中添加该因子后进行测量得出的结果(莫拉莱斯,T. I.,和罗伯茨,A. B.,《生物化学杂志》,263卷,12828 - 12831页,1988年)。在本研究中,我们通过评估外源性肽的作用以及分析软骨外植体中这两种密切相关的TGF-β同工型(TGF-β1和TGF-β2)的生物合成及总量,对它们进行了比较。外源性添加时,TGF-β1和TGF-β2诱导蛋白聚糖合成比基础对照有相当程度的增加,在约5 ng/ml时达到饱和。基础小牛软骨培养物中TGF-β的合成通过以下方式得以证明:(i)细胞内TGF-β的免疫定位;(ii)稳态mRNA水平的Northern印迹分析;以及(iii)从组织提取物和条件培养基中对代谢标记的TGF-β进行免疫沉淀。基础软骨培养物中可提取的TGF-β1和TGF-β2的净含量通过一项功能测定进行评估,该测定涉及抑制CCL - 64貂肺上皮细胞的增殖,并通过夹心酶联免疫吸附测定法进行。主要的同工型是TGF-β1(60 - 85%),并且总的TGF-β1 + TGF-β2超过了蛋白聚糖合成最大激活所需的量。尽管蛋白聚糖合成急剧下降(约两到四倍),但在培养的第2天到第7天之间,这两种同工型的水平保持相对恒定。这表明软骨含有大量的TGF-β,软骨细胞难以轻易获取。我们提出,许多该多肽被隔离在基质中,等待按需释放。